chitosan has been researched along with Angiogenesis, Pathologic in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 28 (56.00) | 24.3611 |
| 2020's | 11 (22.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prashanth, KVH; Punarvasu, TP | 1 |
| Chen, J; Chen, X; Ge, Y; Huang, K; Lin, Z; Lv, Z; Pan, Y; Sun, X; Yao, Q; Yu, H | 1 |
| Barui, A; Chatterjee, J; Dasgupta, S; Gope, A; Kumar, P; Mukhopadhyay, A | 1 |
| Ahmad, FJ; Ahmad, I; Akhter, S; Alam Rizvi, MM; Hafeez, Z; Jain, GK; Zafar, S | 1 |
| Liu, C; Liu, H; Pan, H; Tang, W; Wang, G; Wang, J; Yu, Y | 1 |
| Ahmadi, A; Atyabi, F; Baghaei, M; Baradaran, B; Edalati Fathabad, M; Farhadi, S; Ghalamfarsa, G; Ghasemi Chaleshtari, M; Haghnavaz, N; Hasanzadeh, S; Hojjat-Farsangi, M; Irandoust, M; Jadidi-Niaragh, F; Khazaei-Poul, Y; Masjedi, A; Sabz, G | 1 |
| Chang, Y; Cui, J; Guo, Z; Han, Z; Han, ZC; Huang, H; Li, N; Li, Q; Li, Z; Yue, Z | 1 |
| Ahmadi, A; Boroumand-Noughabi, S; Hassannia, H; Heydari, M; Hojjat-Farsangi, M; Izadi, S; Jadidi-Niaragh, F; Karoon Kiani, F; Keramati, MR; Masjedi, A; Mohammadi, H; Sadat Eshaghi, F; Salimifard, S; Shahdadnejad, K | 1 |
| Jamil, B; Kausar, R; Khan, AU; Shahzad, Y; Ul-Haq, I | 1 |
| Li, R; Liu, X; Wang, X; Wang, Y; Yang, M; Zhang, B | 1 |
| Aghebati-Maleki, L; Hassannia, H; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Jafari, R; Karpisheh, V; Mahmoodpoor, A; Majidi Zolbanin, N; Melnikova, LA; Mohammadi, M; Olegovna Zekiy, A; Sahami Gilan, P; Salehi Khesht, AM | 1 |
| Chen, P; Fan, S; Mei, S; Pang, Y; Shao, F; Wang, J; Xia, C; Zhang, J; Zhu, R | 1 |
| Agrawal, R; Geifman Shochat, S; Larsson, A; Moreno, M; Nirmal, J; Nirmal, S; Pow, PY; Quah, ST; Radhakrishnan, K; Tabitha, TST; Venkatraman, S | 1 |
| Chang, H; Han, H; Jeon, S; Kim, JH; Kim, K; Ko, H; Kwon, IC; Lee, H; Min, J; Na, JH; Park, JH; Shim, MK; Suh, M; Yhee, JY; Yoon, HY | 1 |
| An, Z; Birrer, MJ; Bouchard, RR; Chen, X; Cho, M; Coleman, RL; Deng, H; Gharpure, KM; Haemmerle, M; Han, HD; Hu, W; Jennings, N; Jiang, D; Kingsley, CV; Liu, J; Lopez-Berestein, G; Lyons, Y; Ma, S; Mak, CSL; Mangala, LS; Mora, E; Nagaraja, AS; Noh, K; Pradeep, S; Rupaimoole, R; Shahzad, MMK; Sood, AK; Wen, Y; Wu, SY; Xiong, W; Zhang, N | 1 |
| Chen, C; Chen, G; Liu, Y; Ren, J; Wang, H; Wu, X; Zhang, H; Zhao, Y | 1 |
| Gao, X; Li, Y; Wang, W; Wang, X; Yuan, Z; Zhang, Y | 1 |
| Chi, J; Han, B; Jiang, Z; Liu, W; Peng, Y; Qiao, J | 1 |
| Abd Halim, AA; Hassan, A; Rageh Al-Maleki, A; Rizwan, M; Shahzadi, L; Yahya, R; Yar, M; Zubairi, W | 1 |
| Ding, Y; Li, P; Liang, AB; Wang, L; Xiu, B; Ye, WD; Zhang, WJ; Zhu, Q | 1 |
| Akbuğa, J; Alan, S; Eren, F; Kabasakal, L; Özkan, N; Şalva, E; Turan, SO | 1 |
| Ellenbogen, RG; Erickson, AE; Kievit, FM; Tsao, CT; Wang, K; Zhang, M | 1 |
| Kazem, A; Nafee, N; Nasr, M; Saad, H | 1 |
| Bao, X; Ding, Y; Jin, Y; Wang, C; Wang, W; Wang, X; Wang, Y; Zhou, J | 1 |
| Elçin, AE; Elçin, YM; Finkenzeller, G; Koç, A; Stark, GB | 1 |
| Han, B; Jiang, Z; Li, H; Liu, W; Yang, Y | 1 |
| Bai, H; Cai, J; Chen, ZW; Cheng, X; Huang, D; Jiang, J; Jin, H; Pi, J; Wu, C; Yang, F | 1 |
| Ghandehari, H; Huo, E; Jensen, MM; Poursaid, A | 1 |
| Wen, Z; Xu, Y; Xu, Z | 1 |
| Disis, ML; Florczyk, SJ; Kievit, FM; Leung, MC; Park, JO; Veiseh, O; Zhang, M | 1 |
| Chen, X; Li, X; Li, Z; Liu, X; Qian, Z; Wei, Y; Yi, T; Zhao, X; Zhong, Q; Zhou, L; Zhou, S | 1 |
| Florczyk, SJ; Kievit, FM; Leung, M; Park, JO; Veiseh, O; Wu, J; Zhang, M | 1 |
| Akbuğa, J; Cakalağaoğlu, F; Eren, F; Kabasakal, L; Ozkan, N; Salva, E | 2 |
| Chen, X; Du, L; He, X; Li, X; Li, Z; Qian, Z; Wei, Y; Wen, Y; Zhao, X; Zhou, L | 1 |
| Ao, Q; Gong, Y; He, Q; Zhang, X | 1 |
| Bang, YB; Chang, SH; Cho, CS; Cho, MH; Hong, SH; Jiang, HL; Kim, HJ; Kim, JH; Kim, YK; Lee, HD; Minai-Tehrani, A; Shin, JY; Yoon, TJ; Yu, DY; Yu, KN | 1 |
| Chen, G; Khan, A; Paul, A; Prakash, S; Rao, VT; Shum-Tim, D | 1 |
| Chabrot, P; Dauplat, MM; Fatimi, A; Fraine, PD; Lerouge, S; Ouchchane, L; Rivard, A; Soulez, G | 1 |
| Bravo, P; Ferreira, A; Hamilton-West, C; Ignacio Arias, J; Maldonado, I; Sepulveda, C | 1 |
| Bernas, G | 1 |
| Harish Prashanth, KV; Tharanathan, RN | 1 |
| Hattori, H; Hayashi, T; Ishihara, M; Ishizuka, T; Kikuchi, M; Maehara, T; Matsui, T; Nakamura, S; Obara, K; Ozeki, Y; Saito, Y; Takase, B; Yura, H | 1 |
| Fujita, M; Hattori, H; Ishihara, M; Kanatani, Y; Kikuchi, M; Maehara, T; Masuoka, K; Morimoto, Y; Nakamura, S; Obara, K; Takase, B | 1 |
| Anderson, HK; Chang, SH; Cho, CS; Cho, MH; Colburn, NH; Hwang, SK; Jin, H; Kim, HW; Kim, TH; Lee, HW; Lee, KH; Yang, HS | 1 |
| Cho, CS; Cho, MH; Jin, H; Kim, HW; Kim, TH | 1 |
| Bertrand, JR; Blot, E; Li, H; Lu, H; Maksimenko, A; Malvy, C; Opolon, P; Pillé, JY; Pritchard, LL; Soria, C; Soria, J; Vannier, JP | 1 |
| Chan Kwon, I; Chi, DY; Choi, K; Kang, E; Kim, IS; Kim, JH; Kim, K; Kim, YS; Lee, S; Nam, HY; Park, JH; Park, K; Park, RW | 1 |
| Belligolli, A; Bertani, A; Biagini, G; Bicchiega, V; Damadei, A; Muzzarelli, R; Pugnaloni, A | 1 |
| Allen, GG; Bothwell, MA; Rubel, EW; Santos, PM; Winterowd, JG | 1 |
3 review(s) available for chitosan and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Polymeric materials for embolic and chemoembolic applications.
Topics: Antineoplastic Agents; Chemoembolization, Therapeutic; Chitosan; Drug Carriers; Gelatin Sponge, Absorbable; Humans; Neovascularization, Pathologic; Polyethylene Glycols; Polymers; Vascular Malformations | 2016 |
Angiotherapeutics from natural products: from bench to clinics?
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Biological Products; Chitin; Chitosan; Drug Evaluation, Preclinical; Forecasting; Humans; Ischemia; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Rabbits | 2003 |
Chitosan hydrogel as a drug delivery carrier to control angiogenesis.
Topics: Animals; Biocompatible Materials; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Fibroblast Growth Factor 2; Hydrogels; Mice; Mice, Inbred Strains; Neovascularization, Pathologic; Occlusive Dressings; Paclitaxel; Rabbits; Ultraviolet Rays; Wound Healing | 2006 |
47 other study(ies) available for chitosan and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Self-assembled chitosan derived microparticles inhibit tumor angiogenesis and induce apoptosis in Ehrlich-ascites-tumor bearing mice.
Topics: Animals; Apoptosis; Carbohydrate Conformation; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Drug Screening Assays, Antitumor; Female; Humans; Mice; Neoplasms, Experimental; Neovascularization, Pathologic | 2022 |
Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity.
Topics: Animals; Chitosan; Disease Models, Animal; Folic Acid; Humans; Immunomodulation; Infant, Newborn; Inflammation; Interleukin-6; Mice; MicroRNAs; Neovascularization, Pathologic; Oxygen; Retinopathy of Prematurity; Silicon Dioxide | 2022 |
Chitosan-collagen-fibrinogen uncrosslinked scaffolds possessing skin regeneration and vascularization potential.
Topics: Animals; Chitosan; Collagen; Fibrinogen; Hemostatics; Humans; Mice; Neovascularization, Pathologic; Skin; Tissue Scaffolds; Vascular Endothelial Growth Factor A | 2023 |
Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Female; Humans; Lipids; MCF-7 Cells; Nanocapsules; Neovascularization, Pathologic; Rats; Structure-Activity Relationship | 2020 |
Enhancement and orchestration of osteogenesis and angiogenesis by a dual-modular design of growth factors delivery scaffolds and 26SCS decoration.
Topics: Bone Morphogenetic Protein 2; Bone Regeneration; Chitosan; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Osteogenesis; Porosity; Tissue Scaffolds | 2020 |
Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression.
Topics: Breast Neoplasms; Cell Proliferation; Cell Survival; Chitosan; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Hyaluronic Acid; Interleukin-6; Nanoparticles; Neovascularization, Pathologic; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Microenvironment | 2020 |
IGF-1C domain-modified chitosan hydrogel accelerates cutaneous wound healing by promoting angiogenesis.
Topics: Animals; Carbohydrate Conformation; Cell Proliferation; Cells, Cultured; Chitosan; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hydrogels; Insulin-Like Growth Factor I; Mice; Mice, Transgenic; Neovascularization, Pathologic; Wound Healing | 2020 |
Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chick Embryo; Chitosan; Colonic Neoplasms; Drug Delivery Systems; Drug Liberation; Female; Humans; Interleukin-6; Lactic Acid; Magnetic Resonance Spectroscopy; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Polyethylene Glycols; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared; Xenograft Model Antitumor Assays | 2020 |
Development and pharmacological evaluation of vancomycin loaded chitosan films.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Bandages; Burns; Chitosan; Epidermis; Inflammation; Lipid Peroxidation; Male; Materials Testing; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neovascularization, Pathologic; Oxidative Stress; Rats; Rats, Sprague-Dawley; Regeneration; Skin; Solvents; Spectroscopy, Fourier Transform Infrared; Temperature; Vancomycin; Water; Wound Healing | 2021 |
Preparation, characterization and wound healing effect of alginate/chitosan microcapsules loaded with polysaccharides from Nostoc Commune Vaucher.
Topics: Alginates; Animals; Antioxidants; Bandages; Biocompatible Materials; Capsules; Chitosan; Cross-Linking Reagents; In Vitro Techniques; Lipid Peroxidation; Male; Materials Testing; MicroRNAs; Neovascularization, Pathologic; Nostoc commune; Polysaccharides; Porosity; Rats; Thermodynamics; Vascular Endothelial Growth Factor A; Wound Healing | 2021 |
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Topics: 5'-Nucleotidase; Animals; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Colorectal Neoplasms; Doxorubicin; Drug Compounding; Female; GPI-Linked Proteins; Hyaluronic Acid; Lactates; Mice; Mice, Inbred BALB C; Nanoparticles; Nanotechnology; Neoplasm Invasiveness; Neovascularization, Pathologic; RNA, Small Interfering; RNAi Therapeutics; tat Gene Products, Human Immunodeficiency Virus | 2021 |
The amelioration of cartilage degeneration by photo-crosslinked GelHA hydrogel and crizotinib encapsulated chitosan microspheres.
Topics: Animals; Biomarkers; Cartilage; Chitosan; Chondrocytes; Crizotinib; Disease Models, Animal; Drug Carriers; Drug Liberation; Gene Expression; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Interleukin-1beta; Mice; Microspheres; Neovascularization, Pathologic; Osteoarthritis; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Vascular Endothelial Growth Factor A | 2017 |
Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularization.
Topics: Chitosan; Drug Liberation; Eye; Hydrogels; Neovascularization, Pathologic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A | 2017 |
Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.
Topics: Animals; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Extracellular Matrix; Female; Humans; Mice, Nude; Microvessels; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Tissue Distribution; Tumor Burden; Tumor Microenvironment | 2017 |
Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.
Topics: Animals; Blotting, Western; Calcium-Binding Proteins; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Chitosan; Female; Glycoproteins; Humans; In Vitro Techniques; Integrins; Mice; Mice, Knockout; Nanoparticles; Neoplasm Proteins; Neovascularization, Pathologic; Peptides; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, TIE-2; Twist-Related Protein 1; Wound Healing | 2017 |
Multifunctional Chitosan Inverse Opal Particles for Wound Healing.
Topics: Animals; Anti-Bacterial Agents; Biomass; Chitosan; Colloids; Drug Delivery Systems; Escherichia coli; Fibroblast Growth Factors; Inflammation; Microbial Sensitivity Tests; Neovascularization, Pathologic; Particle Size; Porosity; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Surface Properties; Wound Healing | 2018 |
Chitosan sulfate inhibits angiogenesis via blocking the VEGF/VEGFR2 pathway and suppresses tumor growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chitosan; Dose-Response Relationship, Drug; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred Strains; Neovascularization, Pathologic; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2019 |
Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
Topics: A549 Cells; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carbohydrate Sequence; Carcinoma, Lewis Lung; Cell Movement; Chitosan; Down-Regulation; Drug Carriers; Female; Humans; Lung; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Neovascularization, Pathologic; Solubility; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A | 2019 |
Novel chitosan derivative based composite scaffolds with enhanced angiogenesis; potential candidates for healing chronic non-healing wounds.
Topics: Adenocarcinoma; Apoptosis; Barbiturates; Biocompatible Materials; Cell Line, Tumor; Chitosan; Chorioallantoic Membrane; Drug Delivery Systems; Formates; Humans; Hydrogels; Magnetic Resonance Spectroscopy; Muramidase; Neovascularization, Pathologic; Neovascularization, Physiologic; Polyesters; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Stomach Neoplasms; Tissue Engineering; Tissue Scaffolds; Viscosity; Wound Healing | 2019 |
Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells.
Topics: Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid; Nanoparticles; Neovascularization, Pathologic; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2014 |
Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
Topics: Animals; Breast; Breast Neoplasms; Chitosan; Female; Gene Silencing; Gene Transfer Techniques; Humans; Injections, Intraperitoneal; Interleukin-4; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Plasmids; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Solubility; Transfection; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Cytokines; Drug Resistance, Neoplasm; Female; Hydrogel, Polyethylene Glycol Dimethacrylate; Intercellular Signaling Peptides and Proteins; Mice; Neovascularization, Pathologic; Polyethylene Glycols; Tumor Microenvironment | 2014 |
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53 | 2014 |
A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Chitosan; DNA; Drug Delivery Systems; Gene Transfer Techniques; Genes, p53; Genetic Therapy; Humans; Male; Mice, Inbred BALB C; Neoplasms; Neovascularization, Pathologic; Polyethyleneimine; Receptor, Angiotensin, Type 1; Tetrazoles | 2014 |
Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: In vitro and in vivo studies.
Topics: Adenoviridae; Animals; Biocompatible Materials; Bone and Bones; Cell Proliferation; Chitosan; Durapatite; Freeze Drying; Humans; In Vitro Techniques; Microscopy, Confocal; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Osteoblasts; Osteogenesis; Phenotype; Rats; Rats, Wistar; Regeneration; Tissue Engineering; Tissue Scaffolds; Vascular Endothelial Growth Factor A | 2014 |
Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo.
Topics: Animals; Antigens, CD34; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Chitosan; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Interferon-gamma; Liver Neoplasms; Mice; Neovascularization, Pathologic; Spectrophotometry, Infrared; Spleen; Thymus Gland; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2015 |
Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Chitosan; Chorioallantoic Membrane; Drug Carriers; Human Umbilical Vein Endothelial Cells; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Triterpenes; Ursolic Acid; Wound Healing; Xenograft Model Antitumor Assays | 2016 |
Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chelating Agents; Chitosan; Female; Humans; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Mice; Mice, Nude; Nanoparticles; Necrosis; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2009 |
Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment.
Topics: Alginates; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chitosan; Glioma; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Rats; Tissue Scaffolds | 2010 |
In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Liver Neoplasms; Lymphangiogenesis; Lymphatic Metastasis; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; RNA, Messenger; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor D | 2010 |
Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance.
Topics: Alginates; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Resistance, Neoplasm; Glucuronic Acid; Hexuronic Acids; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Tissue Scaffolds; Xenograft Model Antitumor Assays | 2010 |
Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma.
Topics: Animals; Base Sequence; Chitosan; Drug Delivery Systems; Female; Mammary Neoplasms, Experimental; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2010 |
The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Line, Tumor; Chitosan; Disease Models, Animal; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Xenograft Model Antitumor Assays | 2010 |
Preparation of chitosan films using different neutralizing solutions to improve endothelial cell compatibility.
Topics: Biocompatible Materials; Cell Adhesion; Cell Proliferation; Chitosan; Endothelial Cells; Ethanol; Humans; Microcirculation; Microscopy, Atomic Force; Neovascularization, Pathologic; Phenotype; Sodium Hydroxide; Stress, Mechanical; Surface Properties; Temperature; Tissue Engineering; X-Ray Diffraction | 2011 |
Suppression of tumor growth in H-ras12V liver cancer mice by delivery of programmed cell death protein 4 using galactosylated poly(ethylene glycol)-chitosan-graft-spermine.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Endosomes; Gene Transfer Techniques; Genes, ras; Green Fluorescent Proteins; HeLa Cells; Hepatocytes; Humans; Liver Neoplasms; Mice; Neovascularization, Pathologic; Polyethylene Glycols; Polyethyleneimine; Polymers; Protons; ras Proteins; Spermine | 2012 |
Local delivery of chitosan/VEGF siRNA nanoplexes reduces angiogenesis and growth of breast cancer in vivo.
Topics: Animals; Base Sequence; Cell Division; Chitosan; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2012 |
Genipin-cross-linked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction.
Topics: Adipocytes; Alginates; Animals; Cell Differentiation; Cells, Cultured; Chitosan; Coronary Vessels; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Humans; Iridoids; Male; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Rats; Rats, Inbred Lew; Regenerative Medicine; Stem Cell Transplantation; Stem Cells; Vascular Endothelial Growth Factor A | 2012 |
Embolization and endothelial ablation with chitosan and sodium sotradecol sulfate: preliminary results in an animal model.
Topics: Ablation Techniques; Animals; Arteries; Chitosan; Dose-Response Relationship, Drug; Ear; Embolization, Therapeutic; Endothelial Cells; Foreign-Body Reaction; Hydrogels; Injections, Intra-Arterial; Laser-Doppler Flowmetry; Microcirculation; Models, Animal; Neovascularization, Pathologic; Rabbits; Regional Blood Flow; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Time Factors; Vascular Patency; Viscosity | 2012 |
Comparative effect of human and Trypanosoma cruzi calreticulin in wound healing.
Topics: Animals; Bone and Bones; Calcium; Calreticulin; Cell Adhesion; Cell Movement; Cell Proliferation; Chitosan; Cross-Linking Reagents; Dermis; Endoplasmic Reticulum; Fibroblasts; Glutaral; Granulation Tissue; Humans; Male; Molecular Chaperones; Muscles; Neovascularization, Pathologic; Rabbits; Rats; Recombinant Proteins; Regeneration; Tissue Engineering; Trypanosoma cruzi; Wound Healing | 2015 |
Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Shape; Cells, Cultured; Chick Embryo; Chitosan; Chorioallantoic Membrane; Decapoda; Mice; Molecular Weight; Neovascularization, Pathologic; Oligosaccharides; Peritoneum | 2005 |
Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Stability; Endothelial Cells; Hydrogels; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Photochemistry; Skin Neoplasms | 2005 |
Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice.
Topics: Administration, Inhalation; Aerosols; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Survival; Chitosan; Genes, ras; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Neovascularization, Pathologic; RNA-Binding Proteins; Urocanic Acid | 2006 |
Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells.
Topics: Animals; Apoptosis; Carcinoma; Cell Cycle; Chitosan; Dendritic Cells; Gene Transfer Techniques; Genetic Therapy; Immunotherapy; Interleukin-12; Male; Mannose; Mice; Mice, Inbred BALB C; Nanostructures; Neovascularization, Pathologic | 2006 |
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chitosan; Humans; Infusion Pumps; Mice; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; rhoA GTP-Binding Protein; RNA, Small Interfering | 2006 |
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Topics: Angiogenesis Inhibitors; Animals; Chitosan; Delayed-Action Preparations; Drug Carriers; Glycols; Male; Materials Testing; Melanoma; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Treatment Outcome | 2008 |
Morphological study of the capsular organization around tissue expanders coated with N-carboxybutyl chitosan.
Topics: Animals; Biocompatible Materials; Chitin; Chitosan; Collagen; Cytoplasm; Fibroblasts; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Organelles; Rabbits; Skin; Tissue Expansion Devices | 1991 |
Nerve growth factor: increased angiogenesis without improved nerve regeneration.
Topics: Animals; Chitin; Chitosan; Electromyography; Laminin; Mice; Mice, Inbred Strains; Neovascularization, Pathologic; Nerve Growth Factors; Nerve Regeneration; Sciatic Nerve; Silicones | 1991 |